FMP
Rezolute, Inc.
RZLT
NASDAQ
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
3.3 USD
0.06 (1.82%)
About
ceo
Mr. Nevan Charles Elam J.D.
sector
Healthcare
industry
Biotechnology
website
https://www.rezolutebio.com
exchange
NASDAQ
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is ...
CIK
0001509261
ISIN
US76200L3096
CUSIP
76200L309
Address
201 Redwood Shores Parkway
Phone
650 206 4507
Country
US
Employee
57
IPO Date
Jan 14, 2013
Summary
CIK
0001509261
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
76200L309
ISIN
US76200L3096
Country
US
Price
3.3
Beta
1.32
Volume Avg.
353.92k
Market Cap
130.76M
Shares
-
52-Week
0.72-3.628
DCF
0.26
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-3
P/B
-
Website
https://www.rezolutebio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RZLT News
It looks like there's no news available.
